BSE: 532540 NSE: Ajanta Pharmaceuticals ISIN: INE467B01029 SECTOR: IT Software Company Company’s Website: IPO Date & Price: July 29, 2004 | Rs.
Ajanta Pharmaceuticals Overview:
|Stock Symbol in NSE||Stock Symbol in BSE||Current Price||Market Cap. (Cr)||P/E Ratio||Current EPS|
Ajanta Pharmaceuticals Sector Performance and Peer Comparison with Sector Analysis:
Did You Know?
<Space for Feature Image>
- Ajanta Pharmaceuticals is the
- Its Belong to Group.
Balance Sheets & Profit & Loss Account:
|Year||Mar 2009||Mar 2010||Mar 2011||Mar 2012||Mar 2013||Mar 2014||Mar 2015||Mar 2016||Mar 2017||Mar 2018||Mar 2019||Mar 2020|
Ajanta Pharmaceuticals Share Price Forecast Based on Current Growth +5/-5:
Share Price and EPS Forecast Based on Current Average Growth Rates:
|Next 5 Year (CG)||Next 10 Year (CG)||Next 20 Year (CG)|
Share Price and EPS Forecast Based on Current Average Growth Rates Plus 5%:
|Next 5 Year (CG+5%)||Next 10 Year (CG+10%)||Next 20 Year (CG+20%)|
Share Price and EPS Forecast Based on Current Average Growth Rates Minus 5%:
|Next 5 Year (CG-5%)||Next 10 Year (CG-10%)||Next 20 Year (CG-20%)|
Ajanta Pharmaceuticals Quarterly Result, Date & Street Estimate:
Fundamental Analysis of Ajanta Pharmaceuticals:
Ajanta Pharmaceuticals Share Long Term Investment Price Target:
|V-Guard Long Term Investment Tagets||Price||Qnt.Ratio|
Ajanta Pharmaceuticals Fundamentals SWAT Analysis by AMT
Strengths, Weaknesses, Opportunities, and Threats of Ajanta Pharmaceuticals
- Strengths Analysis will coming Soon.
- Weakness Analysis will coming Soon.
- Opportunity Analysis will coming Soon.
- Threats Analysis will coming Soon.
Where we can See Ajanta Pharmaceuticals in Next 5 Year, 10 Year & 20 Year?
Technical Analysis of Ajanta Pharmaceuticals:
Ajanta Pharmaceuticals Share Weekly Swing Trading Price Target:
|Demand And Supply Zone||Support Levels||Support Price||Resistance Levels||Resistance Price|
Ajanta Pharmaceuticals Share Today Intraday Price Target:
|V-Guard Share Price IntradayTarget Today [Short Selling]||V-Guard Share Price IntradayTarget Today [Long Buying]|
FAQ on Ajanta Pharmaceuticals:
Yes, Ajanta Pharmaceuticals is India Number-1 IT Software company, with lots business potential in next few year. Its Fundamentally strong Stock we recommend to buy at around 20-25 PE Ration price target. Anyway This company is quite famous for Good Dividends.
Ajanta Pharmaceuticals is a Debt free company. Its can easily survived any down turn for 5-10 Quarter business growth.
Currently Ajanta Pharmaceuticals is Trading at P/E Ratio which is
Both and working as a
Do to Covid-19 pandemic Ajanta Pharmaceuticals Share drastically fall.
Its depend on when you and at what price you have buy this share, Ajanta Pharmaceuticals at 20-25 P/E Ration is a excellent buy call for long Term Investment.
Ajanta Pharmaceuticals’s Products/Projects:
IPO, Split, Bonus, Dividend Buyback History:
Ajanta Pharmaceuticals First IPO was initiate on July 29, 2004. equity shares were put on sale during the IPO with a price band of Rs -Rs per equity share.
|CEO Name||Yogesh Agrawal|
|CFO Name||Arvind Agrawal|
|Company Address||Ajanta Pharma Limited, Ajanta House, Charkop, Kandivli West, Mumbai 400067, Maharashtra, India|
|Contact Number||080903 84650 Customer Care Number +91-22-66061000|
|Email Address||[email protected]|
Declaration: Investing in the Stock market is full of Risky. AllMoneyTips.COM doesn’t give any guarantee or warranted on its investment advice. Do your research before investing in the stock market. Our Forecast and buying selling levels of stocks is based on price action and demand and supply zone. There is no guarantee come with our prediction. Take it as advice only. We are not responsible for your losses on your investments.